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Background: The process and effectiveness of knowledge translation (KT) interventions targeting policymakers are
rarely reported. In Cambodia, a low-income country (LIC), an intervention aiming to provide evidence-based knowledge
on pneumonia to health authorities was developed to help update pediatric and adult national clinical guidelines.
Through a case study, we assessed the effectiveness of this KT intervention, with the goal of identifying the barriers to KT
and suggest strategies to facilitate KT in similar settings.
Methods: An extensive search for all relevant sources of data documenting the processes of updating adult and
pediatric pneumonia guidelines was done. Documents included among others, reports, meeting minutes, and email
correspondences. The study was conducted in successive phases: an appraisal of the content of both adult and pediatric
pneumonia guidelines; an appraisal of the quality of guidelines by independent experts, using the AGREE-II instrument; a
description and modeling of the KT process within the guidelines updating system, using the Unified Modeling
Language (UML) tools 2.2; and the listing of the barriers and facilitators to KT we identified during the study.
Results: The first appraisal showed that the integration of the KT key messages in pediatric and adult guidelines
varied with a better efficiency in the pediatric guidelines. The overall AGREE-II quality assessments scored 37%
and 44% for adult and pediatric guidelines, respectively. Scores were lowest for the domains of ‘rigor of development’
and ‘editorial independence.’ The UML analysis highlighted that time frames and constraints of the involved stakeholders
greatly differed and that there were several missed opportunities to translate on evidence into the adult pneumonia
guideline. Seventeen facilitating factors and 18 potential barriers to KT were identified. Main barriers were related to the
absence of a clear mandate from the Ministry of Health for the researchers and to a lack of synchronization between
knowledge production and policy-making.
Conclusions: Study findings suggest that stakeholders, both researchers and policy makers planning to update clinical
guidelines in LIC may need methodological support to overcome the expected barriers.
Keywords: Knowledge translation, Clinical practice guideline, Pneumonia, Low-income countryBackground
Pneumonia still imposes a major burden to populations
and health systems in low-income countries (LIC) al-
though interventions to prevent and treat pneumonia are
known [1-4]. In Cambodia, a tropical LIC, pneumonia is
the leading cause of death among children under five [5].* Correspondence: sgoyet@pasteur-kh.org
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research agency, conducted a large study on pneumonia
which included more than 4,000 patients of all ages [6,7].
This study describes the epidemiology of most acute lower
respiratory infections treated in two major provincial
hospitals [6-9]. Study findings were disseminated via vari-
ous media targeting various audiences. However, in 2011,
one year after the end of this study, those study findings
were neither available to the Cambodian Ministry of
Health (MoH) nor to the Cambodian physician in an
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monia management in Cambodia.
In August 2011, the MoH undertook the revision of
the pediatric and adult guidelines for 180 diseases and
health problems commonly treated in the country, in-
cluding the management of community-acquired pneu-
monia [10,11]. This revision was given to two task forces
of national clinicians coming from several MoH and
nongovernmental organizations’ (NGO) hospitals.
Updating guidelines is a difficult task, particularly in
LIC. Reliable guidelines must be epidemiologically rele-
vant and reflect state-of-the art of medical practice. They
have to be developed in a transparent way to facilitate
their implementation and considering their acceptability
and financial implications is also important [12]. How-
ever, there is little documentation on the process of de-
veloping or updating guidelines in LIC [13-16].
In September 2011, the IPC researchers were informed
by the World Health Organization (WHO) Cambodian
office that a revision of the national guidelines was being
undertaken. Although there was no official demand for
it from the MoH, the IPC researchers endeavored to
provide the MoH with locally relevant and evidence-
based knowledge on pneumonia. IPC researchers facili-
tated the creation of a multidisciplinary working group of
national and international clinicians, biologists, health
program managers and epidemiologists involved in pneu-
monia management in Cambodia, dubbed the CALIBAN
network (‘Community-Acquired Lung Infections, Bacteria
and Antimicrobial Network’) (List 1).
List 1 Summary of the CALIBAN knowledge translation
intervention
1. Detailed description of the intervention
a. Characteristics of those who delivered the
intervention
 Intervention delivered by the CALIBAN group
which included:
– European epidemiologists from a
Cambodian-French research agency (n = 2)
– Cambodian clinicians from the Ministry of
Health (n = 4)
– Cambodian clinicians and biologists from
the National Institute of Public Health
(n = 1)
– Cambodian and international clinicians and
biologists from NGO hospitals (n = 8)
– International clinician affiliated with the
University of Health Sciences (n = 1)
– European clinicians from a Cambodia-based
research agencies (n = 1)
– Foreign health program managers from the
World Health Organization (n = 1) Among the Cambodian clinicians, were the
two experts in charge of drafting the updated
appointed to review the pediatric and the adult
pneumonia guidelines.
– One of them, a pulmonologist, agreed to
chair the CALIBAN group.
– Another CALIBAN Cambodian clinician
was also a member of the Task force in
charge of updating the guidelines.
b. Characteristics of the intervention’s targets
 National Health program managers,
policymakers and clinicians, some of them
belonging to the working group delivering the
intervention
c. Setting
 A low- income country, with limited but
improving research capacities
d. Mode of action
 Build a working group of stakeholders involved
in pneumonia management in the country
 Collect, appraise, analyze, synthesize data
existing on pneumonia etiologies and
antimicrobial profiles, in the literature and
among the working group
 Collectively produce a corpus of evidence
 Produce a report and a synthesis with key
messages adapted to policymakers’ needs
 Disseminate the report and synthesis
 Push for uptake of this evidence and its
translation into guidelines recommendations
 Document the process
 Using:– Direct interactions with the intervention
recipients (meetings, correspondence),
– Written communications (full report and
synthesis translated in local language, all
available online)
– Data collection, analysis and synthesis,
shared with the intervention’s recipientse. Duration
 8 months
f. Adherence
 Limited participation of nationals while
conducting the intervention
2. Assumed output
a. Built up of shared knowledge on pneumonia
based on local evidence
b. Uptake of the key messages about pneumonia
etiologies and antimicrobial resistance and
translation into the CPGs
The CALIBAN group then developed the intervention
summarized in List 1. A systematic review and synthesis
of literature on pneumonia etiologies and antimicrobial
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tries was conducted [17]. The CALIBAN group then
produced a comprehensive report including and an ex-
ecutive summary formatted according to the recommen-
dations of the SUPPORT group to best accommodate
policymakers’ needs [18]. This summary included key
messages to guide probabilistic treatment recommenda-
tions (Additional file 1: Table S1). Documents were trans-
lated into the Khmer national language and were officially
submitted by a national clinician from the CALIBAN group
to the MoH in November 2012. These documents were
also posted on a freely accessible website (http://www.web-
citation.org/6Qo38T6HW).
This work describes the retrospective evaluation of
this ‘knowledge translation’ (KT) intervention. KT is the
process by which ‘stakeholders are aware of and use re-
search evidence to inform their health and healthcare
decision making’ [19]. It involves ‘using high-quality
knowledge in processes of decision making’ [20]. Several
authors have developed KT theories and frameworks
[21-24] but the effectiveness and impact of KT interven-
tions targeting policymakers are rarely reported [19].
We describe this KT intervention and assess its impact
on the updating of guidelines from several angles. Our
objective was to identify the barriers to KT encountered
in this LIC setting, and to suggest strategies to facilitate
KT in similar settings.
Material and methods
Data collection
We retrospectively searched for all relevant sources of
data documenting the CALIBAN intervention and the
pneumonia guidelines. We used contact with key infor-
mants, the IPC and CALIBAN archives, the National
Institute of Public Health and MoH websites. Data collec-
ted included project protocols, reports, published literature,
and meeting minutes from CALIBAN. It also included the
successive drafts of guidelines, email correspondence be-
tween researchers, the CALIBAN network and the Task
force, as well as notes taken during interviews with a key
informant from the NGO who assisted the guidelines
update. The review of these documents enabled us to
describe and model the KT intervention.
Analysis
Impact of the KT intervention on the updated guidelines
Firstly, we compared the CALIBAN key messages with
the updated adult and pediatric guidelines released in
2013 to assess the extent to which the newly issued rec-
ommendations were in line with the key messages
(Additional file 1: Table S1).
We also assessed how well the CALIBAN KT messages
were integrated by examining the rigor and transparency
of the guidelines updating process. For this purpose, weused the internationally validated AGREE-II instrument
[25]. Each guideline was assessed by three appraisers as
recommended by AGREE-II for an optimum reliability.
Appraisers were clinicians and public health specialists
who did not participate in the CALIBAN KT intervention.
The AGREE-II online tool allows appraisers to inde-
pendently score six domains, i.e., scope and purpose,
stakeholder involvement, rigor of development, clarity of
presentation, applicability, and editorial independence.
The tool then sums up all the scores of appraisers and
computes standardized domain scores (expressed on a
scale of 0–100).
UML modeling
Secondly, we modeled and analyzed the CALIBAN KT
process within the ‘guidelines updating’ system, using
the Unified Modeling Language (UML) graphical tools.
The purpose was to describe how this intervention worked
and to provide a framework for assessing its effectiveness.
UML is an object-oriented modeling tool developed in
1997 for documenting, designing, and evaluating complex
systems [26]. It is an effective medium of communication
and development for both theorists and practitioners [27].
It has been used to model different aspects of healthcare
systems [28,29] including the analysis of clinical trials [30].
We initially developed a series of UML ‘use cases.’A ‘use
case’ represents a series of steps defining interactions be-
tween ‘actors’ and a ‘system,’ to successfully achieve a goal.
The main ‘actors’ of the ‘guidelines updating’ system were
identified and depicted as stylized human figures accord-
ing to UML conventions (http://www.webcitation.org/
6Qo2KJcEe) (Figure 1).
Then, we constructed a UML activity diagram display-
ing the sequence of activities conducted during the adult
guideline’s updating (Additional files 2 and 3: Figures S1
and S2). We used this tool to frame and analyze the
dynamics of activities, the interactions between actors
and the documents’ exchanges during the adult guideline
updating. We lacked the detailed information required to
construct the same diagram for the pediatric guideline.
Using both the UML ‘use cases’ and the UML ‘activity
diagram’ we derived a structural class diagram describ-
ing the generic structure of the ‘guidelines updating’ sys-
tem. The structural class enabled us to identify the
system’s classes of objects involved in the system, their
possible interfaces, attributes, collaborations, and rela-
tionships within and between the classes (Figure 2).
Modeling was performed in several successive steps
using UML 2.2 Visio® Microsoft® software.
Identification of barriers and facilitators to KT
Finally, we reviewed our AGREE-II appraisal and our
UML models and listed the barriers and facilitators to
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Figure 1 Use case—Knowledge translation during Clinical Practice Guidelines updating.
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Figure 2 Class diagram—Knowledge translation and Clinical Practice Guidelines updating.
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Table 1 AGREE-II scores for the adult and the pediatric
pneumonia guidelines (standardized domain scores
across appraisers), Cambodia 2013
Clinical practice guidelines
Domain of AGREE II Adult Pediatric Mean
Presentation of scope and
purpose
49% 65% 57%
Stakeholder involvement 37% 31% 34%
Rigor of development 16% 10% 13%
Clarity of presentation 54% 69% 62%
Applicability 18% 38% 28%
Editorial independence 12% 11% 12%
Overall assessment 37% 44% 41%
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de Goede [24,31]. Barriers at the process level are those
encountered during the preparation phase and cover
mutual expectations from researchers and policymakers,
and those related to research findings communication
(transfer). Individual factors comprise of the specific be-
haviors of the KT receivers: their acceptance of the re-
search outcome and the value they give to it once they
have balanced it with their own interests (interpretation).
At the process level, we included in the existing classifi-
cation some factors relating to the interactions between
the stakeholders who produced the evidence on pneu-
monia (the CALIBAN group) and those who received
and were supposed to use it (the MoH and Task forces).
Ethical considerations
The CALIBAN project was based on anonymized acute
lower respiratory infections data – including the IPC
study [6,7] - gathered by research studies, all of which
had obtained ethical clearance from the Cambodian
National Ethics Committee for Human Research [17]. Our
present article only examines the process through which
the CALIBAN project was thought up and developed, and
what obstacles were met. This paper is based on work
which in no way involves interventions or research on
human subjects or animals, nor do study results name
any informants or stakeholders. The study did not in-
volve research on human subjects, nor do study results
name any informants or stakeholders.
Results
Guidelines content appraisal
The integration of the CALIBAN KT key messages var-
ies across adult and pediatric guidelines (Additional file 1:
Table S1).
The pediatric guidelines are well in line with those
messages. They recommends antibiotics which CALIBAN
found effective against the most prevalent bacterial patho-
gens responsible for pneumonia in Cambodia (penicil-
lin A for non-severe cases; penicillin A and gentamicin
as first-line treatment for severe cases, with a switch to
ceftriaxone in case of no improvement or to cloxacillin
if staphylococcal pneumonia is suspected). It also refers
to additional guidelines to treat pneumonia due to the
less frequent pathogens cited by CALIBAN and which
require specific treatments.
Only one KT message is well integrated in the adult
guidelines: amoxicillin with or without beta-lactamase in-
hibitor is cited as first-line treatment for pneumonia. The
guideline cites atypical pathogens as possible pneumonia
etiologies although the CALIBAN group could not firmly
document their prevalence in the country. The second-line
option given for non-severe pneumonia are macrolides
which are not effective against the most prevalentpathogens in adult pneumonia in Cambodia. Macrolides
are also inappropriately recommended as single-drug for
patients hospitalized in intensive care with very severe
pneumonia. Moreover, the guidelines recommend fluoro-
quinolones for first-line treatment for severe pneumonia in
hospitalized patients and for second-line or alternative
treatment for uncomplicated cases. These fluoroquino-
lones are expensive, have side effects, and should be pre-
served to avoid resistance and remain a powerful tool
against tuberculosis, which is highly prevalent in
Cambodia. Finally these guidelines do not mention the
possible use of Amikacin in case of severe pneumonia due
to Gram-negative bacteria, although this was among the
CALIBAN key messages.AGREE-II appraisal
The AGREE-II assessment showed that both guidelines
did not meet some development and editorial independ-
ence standards of rigor (Table 1). Rigor relates to the
source of evidence on which recommendations are based.
It scored 16% and 10% for adult and pediatric guidelines
respectively. The appraisers noted the absence of refe-
rence to local and regional studies on pneumonia. The
CALIBAN summary was annexed to both guidelines, only
at the insistence of the supporting NGO and high-ranking
MoH officials, and no reference was made to it within the
text. Seven out of the nine references cited in the adult
guidelines were Western medical textbooks and data from
Western countries. The pediatric guidelines cited three
WHO documents, one Western guideline, and one scien-
tific article on pneumonia (not open access and with the
study area not mentioned in the abstract).
The AGREE-II criteria on editorial independence scored
12% and 11% for adult and pediatric guidelines, respect-
ively. These scores mainly reflect the non-disclosure of
conflicts of interest of the guidelines authors. Potential
conflicts of interest such as those from drug companies
could not be assessed because they were not disclosed.
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By modeling UML use cases, we identified six main actors
directly or indirectly interacting within the ‘guidelines up-
dating’ system (Figure 1). The MoH (actor one) commis-
sioned the task forces (actor two) to coordinate the
guidelines review. The NGO (actor three) provided logistical
support to the task forces and organized the external review.
The experts (actor four) were the clinician task forces’
members who led the work and wrote the guideline drafts.
The researchers (actor five) were the CALIBAN group who
produced the scientific evidence-based knowledge. The ex-
ternal reviewers (actor six) reviewed the guidelines’ drafts.
The activity diagram shows the activities of four actors
directly involved in the updating of the adult pneumonia
guidelines (Additional file 3: Figure S2). It illustrates how all
four actors interacted several times. It also highlights that
actors missed several opportunities to base this adult guide-
line on evidence (n = 6 red dots in the figure). The time
frames and constraints of the various stakeholders involved
were not the same. Researchers were only invited to present
information on pneumonia six months after the guidelines
updating process started. The experts urged researchers to
communicate their results to finalize their task and meet
the deadlines, while the researchers, bound to scientific
methodology and ethics could not release preliminary and
incomplete findings while the review was under way. Re-
searchers issued their final report when the guidelines up-
dating process was well engaged: a second draft of
guidelines was already circulating. This draft was validated
four months later without any change. Conversely to what
happened with the adult guidelines, the main expert in
charge of updating the pediatric guideline had a long history
of collaboration with pneumonia researchers and endorsed
the modifications suggested by the external reviewers.
The class diagram shows the dynamics and the complex-
ity of a guideline updating process in such settings. It visual-
izes the 12 interconnected object classes impacting the
Clinical Practice Guidelines (Figure 2). Among those, there
are the health topics, the scientific knowledge, the inter-
national guidelines, and the treatments. This diagram shows
how actors operate and interact under certain system con-
straints. It brought out the potential role of pharmaceutical
industries that produce the medicines. These industries
might influence researchers’ and experts’ judgment by sup-
porting them. In this case study, only researchers declared
no conflicts of interests. Experts did not disclose any.
Facilitating and impeding factors to KT
We identified 17 facilitating factors and 18 potential bar-
riers to KT (Table 2). Most facilitating factors and bar-
riers were identified at the KT process level (point 1,
Table 2, n = 13/17 facilitators, and n = 14/18 barriers),
while fewer were found at the Individual level (point 2,
Table 2, n = 4/17 facilitators and n = 3/18 barriers).Most barriers to KT encountered were related to the
lack of synchronization between knowledge production
and policy making (Point 1.1.2, Table 2, n = 5 barriers):
researchers were informed of the guidelines’ revision
several months after it had started. They had no formal
mandate from the MoH. Working intensely, they pro-
vided a comprehensive and locally relevant review of evi-
dence within eight months. However, this pace did not
match the policymaker’s time constraints. We also iden-
tified barriers at the policy-making process (Point 1.1.3,
Table 2, n = 3 barriers). Those factors are intrinsic to the
current situation in Cambodia, such as the limited availabil-
ity of clinicians with expertise, or are more individual-
dependent (e.g., barrier n.9, Table 2). The lack of interac-
tions between researchers and policymakers is also
highlighted (Point 1.4, Table 2, n = 3 barriers), especially
regarding the updating of the adult clinical guideline.
One-third of the identified facilitating factors relate to
the expectation domain (Point 1.1, Table 2, n = 6 factors).
In particular, the policy process received help from several
external stakeholders: the WHO, NGO and the External
review committee (Point 1.1.3, Table 2, n = 4 facilitators).
Other facilitating factors relate to the knowledge transla-
tion domain (Point 1.2, Table 2, n = 4 facilitators).
The difference between the process of updating the
pediatric and the adult guidelines bears on only two
points: the pediatric expert had a long term collaborative
experience of with researchers in pneumonia research
projects, while the expert working on the adult guideline
had very little or none; the pediatric expert agreed to
take into account the suggestions made by the external
review committee while the adult expert argued that
those suggestions came too late in the process.
Discussion
This case-study describes a KT intervention about pneu-
monia in a LIC and assessed its impact on the updating
of two national guidelines for clinical practice using vari-
ous methods. Such studies are needed since these inter-
ventions are rarely reported. Moreover, there is no
consensual guidance to date on how to update national
guidelines in such countries [13,19]. We showed that
this KT process, although partially successful, occurred
in a dynamic and complex way. Comparing the KT
process during the updating of both pediatric and adult
pneumonia guidelines allowed us to identify possible fa-
cilitating and impeding factors to KT in similar situations.
The pneumonia knowledge produced by the CALI-
BAN group was successfully translated into the pediatric
guidelines. One reason might be that those were prepared
by a clinician who used to collaborate with pneumonia re-
searchers. Findings are consistent with what was described
elsewhere: when policymakers have a long and strong ex-
perience of collaboration with researchers, knowledge





1. KT intervention provided relevant, accurate, robust, comprehensive
and accessible information to Policymakers
1. The Task force had not planned to request local evidence from
locally-based researchers
1.1.2 Timing
2. Being members of the KT intervention group, the Experts had a
privileged access to research findings before the final results were
available
2. Limited availability of the Task force -busy with the updating of about
200 guidelines chapters at the same time
3. MoH did not initially inform the Researchers of the guidelines review
process
4. The evidence readily available at the initiation of the guidelines updating
process was not complete enough to be used by Policymakers
5. Researchers started working on building evidence seven months after
the process was initiated by the MoH
6. Policymakers expected the Researchers to provide some evidence
quicker.
1.1.3 Policy process
3. WHO facilitated the contact between Researchers and Policymakers:
WHO informed the Researchers that the guidelines were updated
7. Patients’ representatives were not associated to the process. They could
not relay the need to base the Guidelines updating
on local evidence
4. Policymakers received support from an international NGO for some
organizational aspects of the process (organization of the Task force
meetings, of the External Review Committee…)
8. Limited availability of clinicians with expertise. (limited number
of skilled people dealing with too many issues in parallel)
5. The NGO assisting the Policymakers successfully relayed Researchers’
demand to annex the KT messages to the CPGs
9. The Task force left the Experts deciding to accept or refuse the External
Review Committee’s suggestions for improving the final drafts of
guidelines. The Expert in charge of the adult pneumonia guidelines
did not accept changes suggested by the External Committee
6. The Expert who led the work on the pediatric guideline agreed to take
into account the recommendations issued by the External Review
Committee
1.2 Knowledge Translation domain
7. Research synthesis included key messages 10. No communication was released to the media by the Researchers.
Therefore the process did not receive any media support
8. Research synthesis was written in plain and easy English and translated
into local language
11. Research synthesis and report did not present any logo at their front
page, except the logo of the KT group. This may have limited the
identification of authors and their perceived credibility (but facilitated
the easy appropriation by all co authors)
9. Research synthesis was short and compliant with the SUPPORT
recommendations
10. Research synthesis was widely made permanently available online
1.3 Interactions between policymakers and researchers
1.3.1 Initiated by Policymakers during Guidelines Updating process
11. Policymakers invited the Researchers to participate in one of their
meetings
12. Participation of Researchers in the Task force was limited to one
meeting
12. A clinician who was familiar with Research was appointed by the Task
force to update the pediatric pneumonia guidelines. This clinician had
a long lasting history of collaboration with pneumonia researchers
13. The Expert appointed for the adult pneumonia guideline review
had no or limited previous interactions with Researchers
1.3.2 Initiated by Researchers during the KT intervention
13. Researchers invited national clinicians and Experts appointed by the
Task force to participate in the KT intervention
14. Meetings organized during the KT intervention were conducted
in English which is not the working language of most
clinicians in Cambodia
15. Researchers’ attempts to alert on inappropriate recommendations
published in the adult pneumonia guidelines remained unanswered
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Table 2 Facilitating factors and barriers to KT during the pneumonia guidelines updating, Cambodia 2013 (Continued)
2- Individual level
2.1 Acceptance domain
2.1.1 Perceived robustness of evidence
14. Researchers clearly stated the limitations of their Evidence review in
their synthesis
16. Researchers do not know how the robustness of their findings was
perceived by Policymakers
2.1.2 Perceived credibility of source
15. Data contributing to the KT intervention were provided bystakeholders
known by the policymakers
2.1.3 ‘Fit’ with personal knowledge, values or belief systems, preference and traditions
16. Researchers analyzed data in the light of current challenges for the
national health system (prevention of development of antibiotic
resistance, cost effectiveness)
17. There is not much mutual knowledge on values, belief systems,
preference and traditions between Researchers and Policymakers
2.2 Interpretation domain
Connection with own personal or institutional interests
17. Researchers declared no conflicts of interest in their evidence review 18. Policymakers did not disclose potential conflicts of interest in
the guidelines
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drives the KT ‘interaction model’ considered as an effect-
ive model for optimizing research use [31]. When policy-
makers are aware of research constraints, limitations, and
strengths, they likely incorporate these into policies [33].
Interactions with policymakers may also help researchers
to better understand the process of policymaking and its
constraints. This ‘interaction model’ takes into account
the complexity of the health systems in their context and
the interactive and incremental nature of policy
development.
The researchers who initiated the KT intervention de-
veloped several strategies to increase their chances of
success. First, they invited the clinicians in charge of
writing the guidelines to chair and participate in devel-
oping the KT intervention. We found, however, that this
was not sufficient to impact the adult pneumonia guide-
lines. Similarly, a study in Canada showed that when
policymakers are only involved in the synthesis of re-
search findings, they better understand these findings
but do not necessarily use them [33].
Second, CALIBAN researchers worked on the quality
of the evidence they intended to transfer. They naively
expected that providing only relevant, comprehensive,
and robust evidence to the right persons would be suffi-
cient to influence the policymaking. This assumption
drives the ‘KT push-model’ [34] that was found to be in-
efficient: knowledge utilization does not only depend on
supply of research findings [21,22,24]. Indeed, we showed
that the scientific knowledge supplied by the researchers
did not spontaneously and simply climb what is called the
‘ladder of knowledge utilization’ [34]. CALIBAN findings
were transmitted to relevant stakeholders (first stage of
the ladder). Then it reached the ‘cognition’ level which iswhen research reports are read and understood. But those
reports only reached the ‘reference’ echelon (reports
are cited) after a strong encouragement from various
stakeholders. Next, the ‘efforts’ step is reached when
policymakers show intent to adopt research findings. In
this case study, we showed that the ‘influence’ level
(when results have influenced choices and decisions)
was actually reached only in the case of the pediatric
guideline. ‘Application,’ the ultimate step, is reached
when the evidence gives rise to application and extension
by program managers. This ultimate step may never be
reached.
The last strategy developed by the researchers was to
format their messages to meet the expected needs of the
health policymakers following international and recog-
nized recommendations [18]. Indeed, this strategy is re-
ported as a major facilitating factor by policymakers by
Innvaer’s systematic review of 24 studies [32]. Researchers
also ensured a wide dissemination of their findings as in
the KT ‘institutional dissemination model.’ However, as
shown elsewhere, it probably increased the chances of the
CALIBAN messages being integrated into the guidelines,
but was not sufficient [34].
Most barriers to KT we identified were related to the
poor synchronization between knowledge production
and policy making, and to the lack of mutual under-
standing between researchers and policymakers.
The timing of activities was a major issue in this KT
intervention. The lack of timeliness on the production of
research evidence is frequently perceived as an import-
ant barrier for the effective use of research data, even in
developed countries [32]. Developing long-term collabo-
rations between researchers and policymakers would
probably help overcoming this barrier.
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makers in Cambodia may ignore or mistrust the local re-
search capacity or quality: Western medical textbooks
were cited as references, instead of local data. This may
be due to the lack of appreciation of the value of locally
generated evidence, emerging from poor interactions be-
tween researchers and policymakers. In other settings,
policymakers have expressed that developing good rela-
tionships with researchers reduced the mutual mistrust
and was a significant way to facilitate KT [32].
Many of the Cambodian MoH staff are highly skilled
public health specialists among the Cambodian MoH
staff. Involving these Cambodian public health special-
ists may have prevented the recommendations of non-
adapted and expensive treatments that can jeopardize
public health, as observed in the adult pneumonia
guidelines [35].
It was difficult to assess the relative importance of the
barriers to KT and what determines them, mostly be-
cause of the limited transparency in the updating of the
guidelines. The AGREE-II appraisal highlighted the
possible lack of rigor of development and of ‘editorial
independence.’ Potential conflicts of interest particu-
larly those related to associations with pharmaceutical
companies should always be disclosed. Those compan-
ies might be tempted to use guidelines to promote the
use of their products and therefore to influence expert
judgment [36]. Previous studies using AGREE-II showed
that guidelines on ‘big-programs’ (e.g., HIV, malaria)
scored better, demonstrating the positive effect of funding
and international attention [15,37].
The role of external stakeholders such as the WHO
and, the NGO who assisted the task forces and the exter-
nal review committee was noted as a key facilitating factor
of KT in this study.
The WHO and the NGO played a crucial communi-
cation role, first of all by informally informing the re-
searchers about the MoH agenda to update guidelines
and later by liaising between researchers and policy-
makers. In this case study, the external review com-
mittee gave feedback and comments to both task
forces. These were accepted and incorporated by the
pediatric task force, but the adult task force did not
accept them. Recent recommendations on develop-
ment of guidelines indicate that a review of the a final
drafts must be conducted by clinicians and methodo-
logical experts not involved in preparing the guide-
lines [13].
Lessons learned
From the discussion above, we draw a few lessons and
tentatively make recommendations to researchers and
policymakers seeking to facilitate the KT from research
to health policies and guidelines.To researchers
1. Consult policymakers about their public health
priorities to define research questions and do not
only base research questions on literature reviews or
the advancement of science.
2. Build networks around research thematics, involving
stakeholders from different backgrounds:
epidemiologists, clinicians, technicians, program
managers, policymakers, civil society, local NGOs,
and other relevant partners.
3. Work on the timeliness and the relevance of
evidence shared with policymakers in addition to
accuracy and robustness.
4. Besides scientific articles and progress/finding
reports, prepare findings synthesis, following the
SUPPORT format http://www.webcitation.org/
6Qo2OBAXg. Structured summaries must include
key messages, sources and methodology, scope and
limits of the results and conclusions. Summaries
should be presented in person to key stakeholders,
with time for discussion, rather than simply
handed out.
To policymakers
1. Plan the work on the national clinical guidelines
ahead of time and formally request data from
researchers. Consider the time it takes to obtain the
most robust, comprehensive, and therefore relevant
data on which the guidelines must rely.
2. Publicize the process for developing/updating of
guidelines. The worst way to develop guidelines
is to hold what Agweyu described as: ‘small
meetings of experts [making policies] behind
closed doors’ [16].
3. Seek methodological support. Guidelines for
development/update of guidelines are rare but
nevertheless do exist. In 2007, the ADAPTE
collaboration developed a systematic approach, a
manual and tools to facilitate the adaptation of
existing guidelines to different contexts (http://www.
webcitation.org/6Qo0xEWDn). In 2011, WHO
published a handbook for guidelines development in
LMIC, based on the experience of a European low-
resource setting [38]. Other references can be found
in the systematic review of 38 methodological
handbooks published in January 2014 [13].
4. Involve external experts and officially mandate an
External Review Committee.
5. Define a roadmap for the Experts in charge of drafting
the guidelines, describing the way to interact with
other stakeholders involved in the process
(in particular the external review committee).
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1. Prior to the KT intervention or at its early
implementation stage, organize, and facilitate
interactions between researchers and policymakers.
This potentially makes policymaking and research
more compatible.
2. ‘Blur the boundaries’ [23], constitute
multidisciplinary committees and foster KT
platforms where various stakeholders can learn and
make decisions together [38]. Make policymakers
and the researchers aware of each other’s agendas,
constraints, and objectives. Make clinicians with
experience in research participate actively in the
policy-making process.
3. Identify and involve effective KT coordinators/
facilitators—sometimes called ‘knowledge brokers’
[39]. Their tasks could be to organize meetings,
liaise with involved stakeholders, retrieve and format
the evidence needed to support the guidelines,
prepare recommendation matrices, facilitate
consensus, prepare guideline drafts, and coordinate
internal and external reviews [40].
4. Document and report additional case reports to
further support the development of guidelines for
developing/updating guidelines.
Finally there are also some institutional lessons that
could be derived from this case report:
1. Declaring conflicts of interest should be mandatory
for researchers, tasks forces, and expert committees
involved in guideline development, especially with
regard to guidelines that make recommendations on
medication alternatives.
2. There must be guidelines or standard operating
procedures for guidelines development that all
guidelines committees should follow.
3. The use of available evidence as well as the grading
of evidence should be part of the above guidelines.
4. Task forces should be provided with tools to grade
locally acquired evidence. Otherwise they may
overstate the contribution of western textbooks.
Limitations
The main limitation of this analysis is that it was con-
ducted from the perspective of those who designed and
implemented the KT intervention since it was the only
source available. We used the quality and content ap-
praisals of the updated pneumonia guidelines as a proxy
for KT impact. Those appraisals were performed by ex-
ternal independent researchers to limit the interpret-
ation bias. The modeling analysis was conducted by five
professionals from various backgrounds to also limitpotential bias of analysis. Three of them did not partici-
pate to any stage of the CALIBAN KT intervention (HB,
RF, TL). Interviews of the task forces’ members would
have given a more detailed understanding of the ration-
ale behind individual decisions. Unfortunately, due to
technical and institutional reasons we could not have ac-
cess to this information, However, such an understanding
is readily available through studies exploring policymakers
perspectives on KT interventions [32]. An additional
element of complexity is that some persons with a key
role in the guidelines updating process were also know-
ledge dispensers.Conclusions
This case study provides an overview of a partly suc-
cessful collaboration between researchers and policy-
makers in a LIC and highlights the main missed
opportunities of a KT experience. Longterm and close
interaction between researchers and policymakers was the
main facilitating factor of KT. Other efforts made by the
researchers such as building accurate robust local evi-
dence, formatting it to the needs of policymakers, invit-
ing policymakers to participate in the KT intervention
were not sufficient. Stakeholders—policymakers and re-
searchers—planning to update clinical guidelines in LIC
should receive methodological support to overcome the
expected barriers.Additional files
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